Home Page |
References | OMIM | Gene | GeneReviews | HGMD | HGNC |
GENATLAS PHENOTYPE |
last update : 07-11-2009 |
Symbol | LIS1 |
Location | 17p13.3 |
Name | lissencephaly 1 |
Other name(s) |
|
Corresponding gene | PAFAH1B1 |
Other symbol(s) | ILS |
Main clinical features |
|
Genetic determination | autosomal dominant |
chromosomal | |
Prevalence | account for approximately 75p100 of patients with lissencephaly ( Haverfield 2009) |
Related entries | MDS |
Function/system disorder | congenital malformation |
neurology | |
mental retardation | |
Type | malformation |
Gene product |
Name | platelet activating factor acetyl-hydrolase (PAFAH1B1) |
Mechanism(s) |
Gene mutation | Chromosome rearrangement | Effect | Comments |
| various types
|  
|  
| intragenic mutations or deletions in 44 percent of cases
| deletion
|  
| haploinsufficiency
| microdeletions of the entire LIS1 gene,or microdeletions within the gene in 49 percent of cases
| |
Remark(s) | PAFAH1B1 (LIS1) is involved in 87 percent of ILS cases |
Genotype/Phenotype correlations | truncating or frameshift mutations had severe developmental delay with early-onset seizures, hypotonia, and spastic quadriparesis; patients with genomic deletions/duplications have the same severity; patients with missence or splice site mutation had a less severe clinical course |